Top Story

Reading speed suitable outcome measure for lampalizumab trials

Reading speed suitable outcome measure for lampalizumab trials
February 11, 2016

MIAMI — Results of the MAHALO study support the use of reading speed as a secondary outcome measure in clinical trials for lampalizumab, a speaker told colleagues here.

Lampalizumab (Roche) is a monoclonal antibody fragment that targets factor D and inhibits the progression of geographic atrophy.

In the Journals

Vision-threatening abnormalities possible in infants with presumed Zika virus-associated microcephaly

February 10, 2016
Infants who are born with microcephaly due to congenital infection from presumed exposure to the Zika virus may have vision-threatening abnormalities, according to a…
Meeting News Coverage

Anti-VEGF with targeted retinal photocoagulation does not reduce treatment burden for DME patients

February 10, 2016
MIAMI — Anti-VEGF injections in combination with targeted retinal photocoagulation did not show a decrease in treatment burden in patients with diabetic macular…
Breaking News

TearLab withdraws proposed public offering of common stock

February 10, 2016
TearLab has withdrawn its proposed public offering of common stock, according to a company press release. Due to current market conditions, the company believes that it…

BLOG: Three reasons why Medicare is our best payer

February 10, 2016
The cover story in this issue of Ocular Surgery News addresses the phenomenon of physicians opting out of Medicare. While few in our profession have made this switch…
More News Headlines »
Practical Retina

Comparing Aflibercept, Bevacizumab, and Ranibizumab for DME: Analysis of DRCR Protocol T

Ophthalmic Surgery, Lasers and Imaging Retina, March 2015, Volume 46 Issue 3
More »

Ocular Surface Diseases, Disorders, and Dysfunctions: Volume 1, Number 2

This activity is supported by an educational grant from Shire.

Maintenance of the health of the ocular surface is complex due to the number of potential challenges, including dry eye…
More »
Meeting News CoverageVideo

VIDEO: Allergan looks to have complete platform for glaucoma treatment

February 9, 2016
More »